ESOS (Endoscopic Saphenous Harvesting With an Open CO2 System) Trial

ESOS (Endoscopic Saphenous Harvesting With an Open CO2 System) Trial: a Prospective Randomized Trial for Coronary Artery Bypass Grafting (CABG) Surgery.

The ESOS (Endoscopic Saphenous harvesting with an Open CO2 System) trial is a prospective randomized trial for coronary artery bypass grafting (CABG) surgery to compare endoscopic open CO2 harvesting system versus conventional vein harvesting.

The ESOS (Endoscopic Saphenous harvesting with an Open CO2 System) trial is a prospective randomized trial for coronary artery bypass grafting (CABG) surgery to compare and to test improvement in wound healing, quality of life, safety/efficacy, cost-effectiveness, short and long-term outcomes and vein-graft patency after endoscopic open CO2 harvesting system versus conventional vein harvesting.

Inclusion Criteria:

• Elective planned CABG surgery
• First isolated CABG surgery

Exclusion Criteria:

• Emergency revascularization: patients with hemodynamic instability or requiring inotropic or intra-aortic balloon support
• Previous cardiac surgery
• Planned concomitant valve surgery
• Very varicous veins
• Previous saphenectomy
• History of deep vein thrombosis
• History of suffered trauma on the lower extremity
• Preoperative legs immobilization
• Previous leg wound complications
• Coexisting illness with life expectancy < five years